Patent ID: 8029829
Filing Date: 2011-10-04
Classification: A61K,A61P

Abstract:
1. A method of treating diabetic nephropathy, comprising administering a composition comprising degraded galactomannan and a polyphenol compound to a subject in need thereof, wherein the content of the degraded galactomannan in the composition is from 20 to 80% by weight and the content of the polyphenol compound in the composition is from 20 to 80% by weight wherein 80% or more of the sugar chains constituting the degraded galactomannan has a degree of mannose polymerization of from 22 to 47 units and wherein the polyphenol compound is one or more compounds selected from (+)-catechin, (+)-gallocatechin, (−)-gallocatechin gallate, (−)-epicatechin, (−)-epicatechin gallate, (−)-epigallocatechin, (−)-catechin gallate, (−)-epigallocatechin gallate, gallic acid, free theaflavin, theaflavin monogallate A, theaflavin monogailate B, and theaflavin digallate.